Estrofurate: Difference between revisions
CSV import |
No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 23: | Line 23: | ||
{{stub}} | {{stub}} | ||
<gallery> | |||
File:Estrofurate.svg|Estrofurate | |||
</gallery> | |||
Latest revision as of 20:52, 16 March 2025
Estrofurate is a fibrate used as a lipid-lowering agent. It is marketed under the brand name Normolipol.
Pharmacology[edit]
Estrofurate is a fibrate, a class of drugs that lower levels of lipids in the blood. Fibrates are used to treat conditions such as hyperlipidemia (high cholesterol) and hypertriglyceridemia (high triglycerides). They work by increasing the activity of lipoprotein lipase, an enzyme that breaks down lipids.
Uses[edit]
Estrofurate is used to lower lipid levels in the blood. It is particularly effective at lowering triglycerides, a type of fat found in the blood that can increase the risk of heart disease if levels are too high. It can also lower levels of low-density lipoprotein (LDL), or "bad" cholesterol, and increase levels of high-density lipoprotein (HDL), or "good" cholesterol.
Side Effects[edit]
Like all medications, estrofurate can cause side effects. Common side effects include nausea, vomiting, diarrhea, and stomach pain. Less common side effects can include rash, itching, and hives. In rare cases, estrofurate can cause more serious side effects such as liver damage, gallstones, and pancreatitis.
Interactions[edit]
Estrofurate can interact with other medications, including other lipid-lowering drugs, anticoagulants, and certain antibiotics. It is important to tell your doctor about all the medications you are taking before starting estrofurate.
